300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Colombia
Oman
Cameroon
New Zealand
Australia
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Malawi
Seychelles
Moldova
Botswana
Japan
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
United States
India
Germany
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 20 Life Science VC Funds & Investors in Italy (July 2026)

The most active venture capital funds investing in Italy Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Italy Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Sofinnova Partners
VC Fund
4 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6.6M–$109M
CDP Venture Capital
VC Fund
3 Italy, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $488k–$23M
Indaco Venture Partners
VC Fund
3 Italy, United Kingdom, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Life Science $3.3M–$110M
Claris Ventures
VC Fund
2 Italy, United Kingdom Seed, Series A, Series B Biotechnology, Health Care, Life Science $2.1M–$25M
Principia SGR
VC Fund
2 Italy, United States, United Kingdom Series A, Seed Health Care, Biotechnology, Software $329k–$7.7M
Blue Ocean Finance
VC Fund
1 Italy Venture - Series Unknown Biopharma, Life Science, Biotechnology
Gaiae International
VC Fund
1 Italy Venture - Series Unknown Biopharma, Life Science, Biotechnology
Roche Venture Fund
VC Fund
1 United States, United Kingdom, Spain Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5M–$125M
Club degli Investitori
VC Fund
1 Italy, Switzerland, United Kingdom Seed, Series A, Pre-Seed Health Care, Software, E-Commerce $197k–$30M
AbbVie Biotech Ventures
VC Fund
1 United States, China, Italy Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6M–$115M
MCF Holding
VC Fund
1 Italy Venture - Series Unknown Biopharma, Life Science, Biotechnology
JDRF T1D Fund
VC Fund
1 United States, Canada, France Series A, Series B Biotechnology, Health Care, Medical $7M–$130M
Deep Blue Ventures
VC Fund
1 Italy Venture - Series Unknown Biopharma, Life Science, Biotechnology
Invitalia Ventures
VC Fund
1 Italy, United States, United Kingdom Series A, Seed Software, Medical, Internet $658k–$6.2M
Sparta Capital
VC Fund
1 Italy, Germany Series A, Series B Solar, Life Science, Biotechnology $11M–$16M
LIFTT
VC Fund
1 Italy, United Kingdom, France Seed, Series A Software, Biotechnology, Manufacturing $329k–$21M
ENEA Tech e Biomedical
VC Fund
1 Italy, Finland Venture - Series Unknown, Series A, Grant Health Care, Biotechnology, Medical Device $530k–$21M
EIT Food
VC Fund
1 United Kingdom, Israel, Germany Grant, Non-Equity Assistance, Seed Biotechnology, Food and Beverage, AgTech $1.2k–$11M
Italian Angels for Growth
VC Fund
1 Italy, United States, United Kingdom Seed, Angel, Series A Software, E-Commerce, Health Care $219k–$14M
ReItaly21
VC Fund
1 Italy Venture - Series Unknown Biopharma, Life Science, Biotechnology
Access all 40 VC funds in Italy Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 4 investments in Italy Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 317
  • Round size: Series A $6.6M–$65M; Series B $10M–$109M; Series C $12M–$100M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
  • Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
  • Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.
Show all investments...

CDP Venture Capital
VC Fund · Rome, Lazio, Italy · 3 investments in Italy Life Science startups

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 276
  • Round size: Seed $488k–$8.1M; Series A $3.3M–$23M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $197M in 2021

Portfolio highlights

  • Klaaryo
  • Macingo — Trasporto, spedizioni e traslochi a basso costo. Trasporti economici di auto, moto, barche e mobili in Italia ed Europa. Confronta prezzi e risparmia il 70%
  • Tretau — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 3 investments in Italy Life Science startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B, Series C
  • Geography: Italy, United Kingdom, Switzerland

Investor stats

  • Total investments: 47
  • Round size: Series A $3.3M–$31M; Series B $8.8M–$89M; Series C $16M–$110M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
  • Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
Show all investments...

Claris Ventures
VC Fund · Torino, Piemonte, Italy · 2 investments in Italy Life Science startups

Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 17
  • Round size: Seed $2.1M–$11M; Series A $6.1M–$25M; Series B $7.4M–$20M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Lever Bio — Lever Bio's vision is to be at the forefront of unlocking groundbreaking advancements in biotech, particularly in the field of immuno-oncology. By fostering strategic collaborations with leading researchers, prestigious universities, and innovative research centers, Lever Bio aims to accelerate the development of cutting-edge therapies andtechnologies
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
  • Haptena Therapeutics — Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
Show all investments...

Principia SGR
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Life Science startups

Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 50
  • Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $187M in 2014

Portfolio highlights

  • KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Show all investments...

Blue Ocean Finance
VC Fund · Rome, Lazio, Italy · 1 investments in Italy Life Science startups

Blue Ocean Finance S.p.A is a financial consulting firm focusing on Italian startups and innovative SMEs. The company’s aim is to assist enterprises in achieving their objectives of growth by developing a tailored financial strategy, obtaining new capital and advising them during extraordinary business operations. Funded in Rome in 2018, BlueOcean Finance is well known for its expertise in Corporate Finance, Banking and Financial Advisory.

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Show all investments...

Gaiae International
VC Fund · Gaia, Porto, Portugal · 1 investments in Italy Life Science startups

Gaiae International is a leading importer and exporter of fruits and vegetables.

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Show all investments...

Roche Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Italy Life Science startups

We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 117
  • Round size: Series A $7.5M–$86M; Series B $10M–$125M; Series C $5M–$105M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • AveXis — Discover how Novartis Pharmaceuticals brings innovative medicines to market to enhance health outcomes for patients and offer solutions to healthcare providers.
  • Enthera — Enthera S.r.l. is a new Italian biotech start-up which mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway. Its name comes from the crasis of the terms entero (referring to the intestine) and therapy.Enthera was founded by BiovelocITA in October 2016 in collaboration with the scientists: Prof. Paolo Fiorina and Dr. Francesca D’Addio.
  • MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Show all investments...

Club degli Investitori
VC Fund · Torino, Piemonte, Italy · 1 investments in Italy Life Science startups, 6 in the past 12 months

Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, Switzerland, United Kingdom

Investor stats

  • Total investments: 109
  • Round size: Seed $197k–$8.2M; Pre-Seed $614k–$5.1M; Series A $889k–$30M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • CiaoDott
  • Alomana
  • Quantum Bridge — Quantum Bridge is a pioneer in Distributed Symmetric Key Exchange (DSKE) technology. It offers quantum-safe cybersecurity products and services. Quantum-safe product and services, Quantum-safe roadmap and quantum-safe solutions implementation.
Show all investments...

AbbVie Biotech Ventures
VC Fund · North Chicago, Illinois, United States · 1 investments in Italy Life Science startups

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Italy

Investor stats

  • Total investments: 49
  • Round size: Series A $6M–$53M; Series B $12M–$85M; Series C $39M–$115M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Mozart Therapeutics — The company intended to focus on developing novel immune engagers.
  • Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
  • DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
MCF Holding
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Life Science startups

MCF Holding is a holding company of financial investments that engages in the management of events, retail, and real estate business.

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Show all investments...

JDRF T1D Fund
VC Fund · Boston, Massachusetts, United States · 1 investments in Italy Life Science startups

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 55
  • Round size: Series A $7M–$105M; Series B $18M–$130M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Diasome Pharmaceuticals — Realizing a new life with diabetes.
  • Tetragenetics — Our protein production platform provides recombinant transmembane proteins, including ion channels and GPCRs, for antibody drug discovery
  • Repertoire Immune Medicines — Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
Show all investments...

Deep Blue Ventures
VC Fund · 1 investments in Italy Life Science startups

Deep Blue Ventures is an international holding company that acquires, manages, and scales the next generation of online brands.

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Show all investments...

Invitalia Ventures
VC Fund · Rome, Lazio, Italy · 1 investments in Italy Life Science startups

Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it

Show more...

Investment focus

  • Industry: Software, Medical, Internet
  • Stage:Series A, Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 30
  • Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $89M in 2017

Portfolio highlights

  • Ecomate — The ESG Rating platform for every company
  • BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
  • Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Show all investments...

Sparta Capital
VC Fund · Toronto, Ontario, Canada · 1 investments in Italy Life Science startups

Sparta Capital Ltd. focuses on product development, manufacturing, distribution, sales and service across a range of technologies. The Company's offering includes four different market verticals: transportation, mining, construction and energy (through biomass conversion). These offerings include optimization of energy consumption in thecommercial and manufacturing sectors, construction and energy through biomass conversion, energy conservation in mining, and energy savings in transportation. It is focused on the expansion of a range of divisions, including photoluminescent safety products division, energy audit (EMD) division, biomass division and mining division.

Show more...

Investment focus

  • Industry: Solar, Life Science, Biotechnology
  • Stage:Series A, Series B
  • Geography: Italy, Germany

Investor stats

  • Total investments: 4
  • Round size: Series A $11M–$16M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • B-ON
  • Sunvigo — Sunvigo provides you with cheap solar power from your roof and real green power from the grid.
  • GFBiochemicals — GFBiochemicals is the only company to produce levulinic acid at commercial scale directly from biomass.In 2008, a group of biobased chemical experts saw the significant potential of levulinic acid to replace petroleum-based products across a range of market sectors. GFBiochemicals was founded to develop the production technology needed for thisrevolution in chemicals and biofuels.GFBiochemicals demonstrated these breakthrough technologies in the Caserta plant, in partnership with the University of Pisa and the Polytechnic University of Milan. This commercial-scale plant was retrofitted with new conversion, recovery and purification technology.
Show all investments...

LIFTT
VC Fund · Turin, Piemonte, Italy · 1 investments in Italy Life Science startups

A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 72
  • Round size: Seed $329k–$4.7M; Series A $2.7M–$21M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
  • CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
  • Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Show all investments...

ENEA Tech e Biomedical
VC Fund · Rome, Lazio, Italy · 1 investments in Italy Life Science startups

ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Venture - Series Unknown, Series A, Grant
  • Geography: Italy, Finland

Investor stats

  • Total investments: 13
  • Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
  • Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
  • Health Triage — Health Triage researches, designs, and develops clinical data, new technologies, and applications for the health sector. Their research activities focus on the development of new screening protocols and innovative diagnosis processes, exploiting deep learning to facilitate the acquisition of new technologies through data learned from algorithms andneural networks.
Show all investments...

EIT Food
VC Fund · Belgium, Wisconsin, United States · 1 investments in Italy Life Science startups

EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, AgTech
  • Stage:Grant, Non-Equity Assistance, Seed
  • Geography: United Kingdom, Israel, Germany

Investor stats

  • Total investments: 117
  • Round size: Seed $226k–$11M; Grant $23k–$531k; Non-Equity Assistance $1.2k–$32k
  • Lead/follow: 66% lead, 34% follow

Portfolio highlights

  • constellr — Smart Farming and Climate Monitoring from Space. At constellr, we are using cutting-edge beyond-visual imaging technology to revolutionise the way we assess crucial aspects of our planet's health.
  • Hooked Foods — Leading the transition to a harmless seafood system by serving healthy vegan seafood for everybody to truly enjoy.
  • Óir na Farraige — Óir na Farraige aims to create a scalable seaweed farming system in Irish waters, offering a sustainable alternative to wild-harvested seaweed for biostimulant manufacturing.
Show all investments...

Italian Angels for Growth
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Life Science startups, 7 in the past 12 months

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Angel, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 104
  • Round size: Seed $329k–$5.9M; Angel $219k–$1.2M; Series A $2.7M–$14M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
  • AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
  • Alomana
Show all investments...

ReItaly21
VC Fund · 1 investments in Italy Life Science startups

ReItaly21 is an investment firm.

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Genoa Instruments — Genoa Instruments is an innovative startup dedicated to transforming the field of biomedical and health research through advanced super-resolution optical microscopy. Our groundbreaking optical microscope uniquely integrates spatial and temporal super-resolution for structural and functional imaging in living samples with unprecedented detail. Ourmission is to make high-resolution imaging accessible to all, fostering scientific discovery and advancing healthcare research.
Show all investments...

Life Science VC funding in Italy at a glance

Stats across 28 deals from 40 investors.

40
investors
in Italy Life Science startups
28
deals
in Italy Life Science startups
$4.4M
median round
in Italy Life Science startups
50%
lead investors
lead at least one round
29%
Grant
most common funding stage

Access all 40 VC funds in Italy Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 40 VC funds investing in Italy Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists